Overview on an Originate AngiotensinⅡReceptor-Neprilysin Inhibitor with Double Effect:Sacubitril/Val-sartan / 中国药师
China Pharmacist
;
(12): 1167-1169, 2016.
Artículo
en Chino
| WPRIM
| ID: wpr-494913
ABSTRACT
An originate angiotensin Ⅱreceptor-neprilysin inhibitor sacubitril/valsartan with double effect and a new active mode can not only promote the protection of heart and neuroendocrine system , but also inhibit renin-angiotensin-aldosterone system .Sacubi-tril/valsartan is the first and only one conformed by clinical trials with better efficacy when compared with standard therapy drug enala -pril, and its safety is higher as well .Sacubitril-valsartan represents a promising new treatment option for heart failure patients with low-ered risk of cardiovascular death and hospitalization for heart failure .
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
China Pharmacist
Año:
2016
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS